BiotechTube

SYNB1020

Phase 1/2Terminated
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cirrhosis

Conditions

Cirrhosis

Trial Timeline

Mar 19, 2018 โ†’ Jul 19, 2019

NCT ID
NCT03447730

About SYNB1020

SYNB1020 is a phase 1/2 stage product being developed by Synlogic for Cirrhosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT03447730. Target conditions include Cirrhosis.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03447730Phase 1/2Terminated

Competing Products

20 competing products in Cirrhosis

See all competitors
ProductCompanyStageHype Score
peginterferon alfa-2a 180ฮผg + peginterferon alfa-2a 90ฮผg + ribavirinChugai PharmaceuticalPhase 3
77
Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)ShionogiPhase 2
52
Mesenchymal Stem CellRohto PharmaceuticalPre-clinical
23
Bumetanide + FurosemideJohnson & JohnsonPhase 3
77
Mesenchymal stem cellRohto PharmaceuticalPhase 1/2
41
ZibotentanAstraZenecaPhase 1
33
Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet) + Part A: zibotentan (dose B) + dapagliflozin + Part B: Placebo (matching zibotentan capsule & matching dapagliflozin tablet) + Part B: placebo (matching zibotentan capsule) + dapagliflozin + Part B: zibotentan (dose A) + dapagliflozin + Part B: zibotentan (dose B) + dapagliflozin + Part B: zibotentan (dose C) + dapagliflozinAstraZenecaPhase 2
52
Placebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet) + Zibotentan + placebo (placebo matching dapagliflozin tablet) + Zibotentan + dapagliflozinAstraZenecaPhase 2
52
ARQ 197MerckPhase 1
33
Grazaoprevir/Elbasavir + Grazaoprevir/Elbasavir/RBVMerckApproved
85
Steroids + Basiliximab + Tacrolimus + Enteric-coated Mycophenolic acid (EC-MPA)NovartisApproved
85
Telbivudine + Enecavir + AdefovirNovartisApproved
85
Serelaxin + PlaceboNovartisPhase 2
52
Terlipressin acetate + Serelaxin (RLX030)NovartisPhase 2
52
PasireotideNovartisPhase 1
33
HPN-100 + PlaceboAmgenPhase 2
51
Placebo Comparator + Experimental: Seladelpar 50 mg + Experimental: Seladelpar / MBX-8025 200 mgGilead SciencesPhase 2
51
TDF/FTC/LPV/r + PlaceboGilead SciencesPre-clinical
22
MBX-8025 2 mg Capsule + MBX-8025 5 mg Capsule + MBX-8025 10 mg CapsuleGilead SciencesPhase 2
51
Seladelpar 5 mg Capsule + Seladelpar 10 mg CapsuleGilead SciencesPhase 3
76

Other Products from Synlogic

SYNB1934v1 + PlaceboPhase 3
69
SYNB1618 + SYNB1934Phase 2
44
SYNB1618 + PlaceboPhase 1/2
33
SYNB1891 + AtezolizumabPhase 1
25
Placebo + SYNB1020Phase 1
25